Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets

Acta Neuropathologica

Volumn 131, Issue 6, 2016, Pages 903-910

  Sahm, Felix ^a,b   Schrimpf, Daniel ^a,b   Jones, David T W ^b   Meyer, Jochen ^b   Kratz, Annekathrin ^a,b   Reuss, David ^a,b   Capper, David ^a,b   Koelsche, Christian ^a,b   Korshunov, Andrey ^a,b   Wiestler, Benedikt ^b,c   Buchhalter, Ivo ^b   Milde, Till ^b   Selt, Florian ^b   Sturm, Dominik ^b   Kool, Marcel ^b   Hummel, Manuela ^b   Bewerunge Hudler, Melanie ^b   Mawrin, Christian ^d   Schüller, Ulrich ^e   Jungk, Christine ^c   Wick, Antje ^b,c   Witt, Olaf ^b   Platten, Michael ^b,c   Herold Mende, Christel ^c   Unterberg, Andreas ^c   Pfister, Stefan M ^b   Wick, Wolfgang ^b,c   von Deimling, Andreas ^a,b   more..

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^d OTTO VON GUERICKE UNIVERSITY   (Germany)

^e UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; FIBROBLAST GROWTH FACTOR RECEPTOR 1; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P53; STAT6 PROTEIN;

ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; GENE FREQUENCY; GENE MUTATION; GENETIC VARIATION; GLIOBLASTOMA; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MEDULLOBLASTOMA; MENINGIOMA; NEUROPATHOLOGY; NEXT GENERATION SEQUENCING; OLIGODENDROGLIOMA; PILOCYTIC ASTROCYTOMA; PRIORITY JOURNAL; PROMOTER REGION; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR DIAGNOSIS; BRAIN NEOPLASMS; GENETIC PROCEDURES; GENETICS; HIGH THROUGHPUT SEQUENCING; MOLECULAR PATHOLOGY; MUTATION; PROCEDURES;

BRAIN NEOPLASMS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MOLECULAR PROBE TECHNIQUES; MUTATION; PATHOLOGY, MOLECULAR;

EID: 84949991007     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-015-1519-8     Document Type: Article

References (36)

1. BCL to fastq conversion. https://www.support.illumina.com/content/dam/illumina-support/documents/documentation/software_documentation/bcl2fastq/bcl2fastq2-v216-Software-Guide-15051736-E.pdf. Accessed 8 Oct 2015
2. Fastqc. http://www.bioinformatics.babraham.ac.uk/projects/fastqc/. Accessed 8 Oct 2015
3. Picard duplicate removal. http://broadinstitute.github.io/picard/. Accessed 8 Oct 2015
4. SAMtools. https://samtools.github.io/hts-specs/SAMv1.pdf. Accessed 8 Oct 2015
5. SAMtools mpileup. http://www.samtools.sourceforge.net/mpileup.shtml. Accessed 8 Oct 2015
6. SAMtools vcf. http://samtools.github.io/hts-specs/VCFv4.2.pdf. Accessed 8 Oct 2015
7. Capper D, Preusser M, Habel A, Sahm F, Ackermann U, Schindler G et al (2011) Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody. Acta Neuropathol 122(1):11–19
8. Choi BD, Archer GE, Mitchell DA, Heimberger AB, McLendon RE, Bigner DD et al (2009) EGFRvIII-targeted vaccination therapy of malignant glioma. Brain Pathol 19(4):713–723
9. Cimino PJ, Bredemeyer A, Abel HJ, Duncavage EJ (2015) A wide spectrum of EGFR mutations in glioblastoma is detected by a single clinical oncology targeted next-generation sequencing panel. Exp Mol Pathol 98(3):568–573
10. Do H, Dobrovic A (2015) Sequence artifacts in DNA from formalin-fixed tissues: causes and strategies for minimization. Clin Chem 61(1):64–71
11. Do H, Wong SQ, Li J, Dobrovic A (2013) Reducing sequence artifacts in amplicon-based massively parallel sequencing of formalin-fixed paraffin-embedded DNA by enzymatic depletion of uracil-containing templates. Clin Chem 59(9):1376–1383
12. Hovelson DH, McDaniel AS, Cani AK, Johnson B, Rhodes K, Williams PD et al (2015) Development and validation of a scalable next-generation sequencing system for assessing relevant somatic variants in solid tumors. Neoplasia 17(4):385–399
13. Hovestadt V, Zapatka M. Enhanced copy-number variation analysis using Illumina 450 k methylation arrays. https://www.bioconductor.org/packages/release/bioc/html/conumee.html. Accessed 8 Oct 2015
14. Hummel M, Bonnin S, Lowy E, Roma G (2011) TEQC: an R package for quality control in target capture experiments. Bioinformatics 27(9):1316–1317
15. Jones DT, Hutter B, Jager N, Korshunov A, Kool M, Warnatz HJ et al (2013) Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma. Nat Genet 45(8):927–932
16. Kool M, Jones DT, Jager N, Northcott PA, Pugh TJ, Hovestadt V et al (2014) Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition. Cancer Cell 25(3):393–405
17. Korshunov A, Meyer J, Capper D, Christians A, Remke M, Witt H et al (2009) Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma. Acta Neuropathol 118(3):401–405
18. Li H, Durbin R (2010) Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 26(5):589–595
19. Louis DN, Perry A, Burger P, Ellison DW, Reifenberger G, von Deimling A et al (2014) International Society Of Neuropathology-Haarlem consensus guidelines for nervous system tumor classification and grading. Brain Pathol 24(5):429–435
20. Louis DN, Virgin HWT, Asa SL (2011) “Next-generation” pathology and laboratory medicine. Arch Pathol Lab Med 135(12):1531–1532
21. Malapelle U, Vigliar E, Sgariglia R, Bellevicine C, Colarossi L, Vitale D et al (2015) Ion Torrent next-generation sequencing for routine identification of clinically relevant mutations in colorectal cancer patients. J Clin Pathol 68(1):64–68
22. Manson-Bahr D, Ball R, Gundem G, Sethia K, Mills R, Rochester M et al (2015) Mutation detection in formalin-fixed prostate cancer biopsies taken at the time of diagnosis using next-generation DNA sequencing. J Clin Pathol 68(3):212–217
23. McPherson A, Hormozdiari F, Zayed A, Giuliany R, Ha G, Sun MG et al (2011) deFuse: an algorithm for gene fusion discovery in tumor RNA-Seq data. PLoS Comput Biol 7(5):e1001138
24. Mosen-Ansorena D, Telleria N, Veganzones S, De la Orden V, Maestro ML, Aransay AM (2014) seqCNA: an R package for DNA copy number analysis in cancer using high-throughput sequencing. BMC Genom 15:178
25. Obenchain V, Lawrence M, Carey V, Gogarten S, Shannon P, Morgan M (2014) VariantAnnotation: a bioconductor package for exploration and annotation of genetic variants. Bioinformatics 30(14):2076–2078
26. Reuss DE, Kratz A, Sahm F, Capper D, Schrimpf D, Koelsche C et al (2015) Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities. Acta Neuropathol 130(3):407–417
27. Reuss DE, Mamatjan Y, Schrimpf D, Capper D, Hovestadt V, Kratz A et al (2015) IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHO. Acta Neuropathol 129(6):867–873
28. Reuss DE, Sahm F, Schrimpf D, Wiestler B, Capper D, Koelsche C et al (2015) ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an “integrated” diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma. Acta Neuropathol 129(1):133–146
29. Rimmer A, Phan H, Mathieson I, Iqbal Z, Twigg SR, Consortium WGS et al (2014) Integrating mapping-, assembly- and haplotype-based approaches for calling variants in clinical sequencing applications. Nat Genet 46(8):912–918
30. Schumacher T, Bunse L, Pusch S, Sahm F, Wiestler B, Quandt J et al (2014) A vaccine targeting mutant IDH1 induces antitumour immunity. Nature 512(7514):324–327
31. Schweizer L, Koelsche C, Sahm F, Piro RM, Capper D, Reuss DE et al (2013) Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 protein. Acta Neuropathol 125(5):651–658
32. Serizawa M, Yokota T, Hosokawa A, Kusafuka K, Sugiyama T, Tsubosa Y et al (2015) The efficacy of uracil DNA glycosylase pretreatment in amplicon-based massively parallel sequencing with DNA extracted from archived formalin-fixed paraffin-embedded esophageal cancer tissues. Cancer Genet 208(9):415–427
33. Sturm D, Witt H, Hovestadt V, Khuong-Quang DA, Jones DT, Konermann C et al (2012) Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 22(4):425–437
34. Suva ML, Louis DN (2013) Next-generation molecular genetics of brain tumours. Curr Opin Neurol 26(6):681–687
35. Tsiatis AC, Norris-Kirby A, Rich RG, Hafez MJ, Gocke CD, Eshleman JR et al (2010) Comparison of Sanger sequencing, pyrosequencing, and melting curve analysis for the detection of KRAS mutations: diagnostic and clinical implications. J Mol Diagn JMD 12(4):425–432
36. Wang K, Li M, Hakonarson H (2010) ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acid Res 38(16):e164